Cdc42EP2 activators engage in the modulation of actin cytoskeletal dynamics and associated cellular processes. These compounds can influence the actin architecture either by stabilizing actin filaments, altering the availability of actin monomers, or by modulating the activity of signaling pathways that govern actin polymerization and cell morphology. Molecules like Jasplakinolide function by binding to actin filaments and stabilizing them against disassembly, thus maintaining a polymerized state that can facilitate the actin-related functions of Cdc42EP2. Conversely, agents such as Cytochalasin D and Latrunculin A disrupt actin polymerization dynamics, indirectly leading to a compensatory increase in filamentous actin formation potentially linked to the Cdc42EP2 pathway. Additionally, other compounds, like Y-27632 and NSC 23766, target specific proteins like ROCK and Rac1, which are integral to the signaling cascades that control actin filament assembly and cell shape, indirectly influencing the activity of Cdc42EP2 through these pathways.
Moreover, within this chemical class, certain compounds exert their effects through modulation of intracellular messenger systems. For instance, Phorbol 12-myristate 13-acetate (PMA) activates Protein Kinase C, which plays a pivotal role in a multitude of cellular processes including the reorganization of the actin cytoskeleton. The broad-spectrum action of Forskolin, through the elevation of cAMP levels, affects various signaling pathways that can lead to cytoskeletal rearrangements, thereby potentially enhancing the activity of Cdc42EP2. Ionomycin, a calcium ionophore, disrupts calcium homeostasis, triggering cascades that converge on actin cytoskeletal alterations.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
An actin polymerization inhibitor that can increase the pool of monomeric G-actin, potentially enhancing actin filament assembly downstream of Cdc42EP2. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Binds to actin monomers and prevents their polymerization, leading to increased levels of monomeric actin which could indirectly stimulate actin nucleation and elongation activities of Cdc42EP2. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
A cyclic peptide that stabilizes actin filaments and prevents their depolymerization, potentially enhancing the actin filament assembly function of Cdc42EP2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
A diester of phorbol that acts as a potent activator of Protein Kinase C (PKC), leading to actin cytoskeletal rearrangements that may enhance Cdc42EP2 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A selective inhibitor of ROCK, which when inhibited can lead to increased actin cytoskeletal rearrangements and potentially enhance Cdc42EP2 activity. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
A small molecule inhibitor of the Rac1 GTPase-activating protein interaction, leading to increased Rac1 activity which may have downstream effects on Cdc42EP2 activity. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
A small molecule inhibitor of formin homology 2 domains, which can lead to alterations in actin dynamics potentially affecting Cdc42EP2's role in actin filament assembly. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
As a bioactive lipid, PGE2 can activate signaling pathways that lead to actin cytoskeletal rearrangements, possibly enhancing Cdc42EP2 function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase leading to an increase in cAMP, which can have a wide range of effects including modulation of the actin cytoskeleton, potentially influencing Cdc42EP2 activity. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
A calcium ionophore that raises intracellular calcium levels, which can activate pathways leading to actin remodeling and possibly affect Cdc42EP2. | ||||||